Jason Gardner
2020 - Dianthus Therapeutics
In 2020, Jason Gardner earned a total compensation of $3.1M as President and Chief Executive Officer at Dianthus Therapeutics, a 88% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $262,000 |
|---|---|
| Option Awards | $2,309,592 |
| Salary | $530,000 |
| Other | $1,256 |
| Total | $3,102,848 |
Gardner received $2.3M in option awards, accounting for 74% of the total pay in 2020.
Gardner also received $262K in non-equity incentive plan, $530K in salary and $1.3K in other compensation.
Rankings
In 2020, Jason Gardner's compensation ranked 3,743rd out of 13,090 executives tracked by ExecPay. In other words, Gardner earned more than 71.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,743 out of 13,090 | 71st |
Division Manufacturing | 1,483 out of 5,621 | 74th |
Major group Chemicals And Allied Products | 558 out of 2,254 | 75th |
Industry group Drugs | 483 out of 1,954 | 75th |
Industry Pharmaceutical Preparations | 364 out of 1,459 | 75th |
Source: SEC filing on April 21, 2021.
Gardner's colleagues
We found two more compensation records of executives who worked with Jason Gardner at Dianthus Therapeutics in 2020.
News
Dianthus Therapeutics Former President, Chief Financial and Operating Officer Stephen Mahoney's 2023 pay jumps 48% to $1.7M
April 11, 2024
Dianthus Therapeutics CEO Jason Gardner's 2021 pay falls 28% to $2.2M
May 2, 2022
Marqeta CEO Jason Gardner's 2021 pay jumps 7,132% to $224M
April 25, 2022
Dianthus Therapeutics CEO Jason Gardner's 2020 pay jumps 88% to $3.1M
April 21, 2021
Dianthus Therapeutics CEO Jason Gardner's 2018 pay jumps 692% to $4.7M
April 25, 2019